Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
19.56
-0.04 (-0.20%)
Oct 23, 2026, 4:00 PM EDT - Market closed

Sabra Health Care REIT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,9974,7234,0983,3002,8713,096
Market Cap Growth
14.18%15.25%24.19%14.92%-7.27%-13.86%
Enterprise Value
7,3847,1216,5035,5765,2695,259
Last Close Price
19.5618.1215.4911.809.359.31

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Price/FFO Ratio
18.6112.2411.399.297.308.10
Price/AFFO Ratio
12.6512.3310.838.876.546.90
PE Ratio
74.7930.3532.34239.86--
PS Ratio
5.786.095.835.125.407.98
PB Ratio
1.821.671.501.180.940.92
P/OCF Ratio
13.4513.5513.2010.989.098.69

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
8.559.189.268.659.9013.55
EV/EBITDA Ratio
20.0015.9315.4414.0916.3123.70
EV/EBIT Ratio
44.8526.8725.3625.5137.15178.65

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.960.900.890.870.820.71
Debt / EBITDA Ratio
7.115.665.746.117.7610.81
Net Debt / Equity Ratio
0.870.870.860.840.800.68
Net Debt / EBITDA Ratio
6.475.515.575.987.5710.29
Asset Turnover
0.160.140.130.120.090.07
Quick Ratio
3.251.471.691.310.570.83
Current Ratio
3.571.812.161.710.711.09
Return on Equity (ROE)
2.39%5.59%4.57%0.47%-2.41%-3.34%
Return on Assets (ROA)
1.90%3.07%3.00%2.45%1.51%0.31%
Return on Invested Capital (ROIC)
2.94%4.98%4.89%3.53%2.50%0.51%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
1.34%3.29%3.09%0.42%-2.70%-3.66%
Dividend Yield
6.13%6.40%6.96%8.41%9.65%8.93%
Payout Ratio
458.84%186.04%221.09%2016.92%--
Buyback Yield / Dilution
-5.18%-3.58%-1.40%-0.80%-5.42%-5.70%
Total Shareholder Return
0.96%2.81%5.56%7.61%4.23%3.23%
SEC Filings: 10-K · 10-Q